Ocular Drug Delivery

Ocular drug delivery presents unique challenges and opportunities. Eye tissues can be accessed directly with relative ease using topical eye drops. However, the loading and ocular absorption of drugs are limited using traditional solution and suspension formulations, particularly for compounds with low aqueous solubility. Consequently, Bend Research has developed an amorphous nanoparticle platform for ocular delivery of low-solubility compounds.

Topics: 
Bioavailability Enhancement